iCardiac Completes Industry's Largest Validation Study of Highly Automated QT Analysis
September 9th 2008iCardiac Technologies, Inc., which develops and implements advanced cardiac safety biomarkers, today announced the successful completion of the industry’s largest validation study for an automated ECG analysis technology.
QPS' Bio-Kinetic Clinical Applications Phase I Unit Announces Collaboration with Quintiles
September 9th 2008QPS' clinical research unit, Bio-Kinetic Clinical Applications, announces a joint collaboration with Quintiles that creates an integrated Cardiac Safety Service for sponsors by incorporating clinical conduct, core ECG laboratory support, independent cardiologist and medical monitor oversight, pharmacokinetic and statistical analysis, and reporting of cardiac safety trials.
Phase Forward Acquires Clarix LLC
September 5th 2008Phase Forward (NASDAQ: PFWD), a provider of data management solutions for clinical trials and drug safety, today announced that it has acquired privately held Clarix LLC, a provider of fully Web-integrated interactive response technology (IRT), for $40 million in cash.
Rho Brings Multi-Million Dollar Federal Contract to RTP Area
September 4th 2008Rho, Inc., and the National Institutes of Health (NIH), is pleased to announce that the National Institute of Allergy and Infectious Diseases (NIAID) has awarded Rho a six-year, $38.9 million contract to provide biostatistical, data management, and safety services to the Immune Tolerance Network (ITN).
Biomedical Systems Announces Vice President, Imaging Services
August 27th 2008Biomedical Systems, a global provider of centralized diagnostic testing for the pharmaceutical and medical device industry, recently announced the promotion of Sam Dranoff to Vice Present of Business Development, Imaging Services.
Foundation Formed to Improve Data Quality in Clinical Trials
August 25th 2008The Foundation for Improving Data Quality (FIDQ) recently held its first meeting in Washington, DC, to outline future efforts to refine methodologies that increase the precision of subjective endpoints used in clinical trials.
Parexel Data Indicate U.S. Marketing Applications for New Molecular Entities Bounce Back
August 25th 2008New data from PAREXEL International Corporation, a leading global biopharmaceutical services organization, reveal that U.S. marketing applications for new molecular entities (NMEs) surged 33 percent in 2007.
Dutch company Factory CRO chooses US-based AmeriStart
August 22nd 2008AmeriStart announced that it has signed a sales, marketing, and business development services contract with Factory CRO, a leading international clinical research organization that specializes in conducting medical device studies for FDA and EU approvals.
Good Products Launches ValMan to Facilitate Validation Project Management
August 12th 2008Good Products, a leading provider of Enterprise Content Management (ECM) solutions for the pharmaceutical and biopharmaceutical industries, announces the availability of its new Validation Project Management tool ValMan.
Velos Set to Clear 50 Percent Market Penetration of Large U.S. Clinical Research Sites by Year End
August 7th 2008Velos, Inc., the resource for clinical trial management information systems for large investigator sites, today announced it will cross the 50 percent market penetration threshold by year end.